rs35207712
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_003999.3(OSMR):c.505G>A(p.Val169Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000433 in 1,613,604 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_003999.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSMR | NM_003999.3 | c.505G>A | p.Val169Ile | missense_variant | 5/18 | ENST00000274276.8 | NP_003990.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSMR | ENST00000274276.8 | c.505G>A | p.Val169Ile | missense_variant | 5/18 | 1 | NM_003999.3 | ENSP00000274276 | P1 | |
OSMR | ENST00000502536.5 | c.505G>A | p.Val169Ile | missense_variant | 5/7 | 1 | ENSP00000422023 |
Frequencies
GnomAD3 genomes AF: 0.00237 AC: 361AN: 152158Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.000661 AC: 166AN: 251238Hom.: 0 AF XY: 0.000486 AC XY: 66AN XY: 135776
GnomAD4 exome AF: 0.000231 AC: 338AN: 1461328Hom.: 0 Cov.: 32 AF XY: 0.000206 AC XY: 150AN XY: 726966
GnomAD4 genome AF: 0.00237 AC: 361AN: 152276Hom.: 2 Cov.: 33 AF XY: 0.00246 AC XY: 183AN XY: 74456
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 29, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at